[1] 王玲.基于医院信息系统开展药品不良反应监测研究[J].中国药物警戒, 2015, 12(4): 229-231, 240. [2] van Grootheest K, de Jong-van den Berg L. Patients' role in reporting adverse drug reactions[J]. Expert opinion on drug safety, 2004, 3(4): 363-368. [3] de Langen J, van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in The Netherlands three years of experience[J]. Drug Safety, 2008, 31(6): 515-524. [4] Avery A J, Anderson C, Bond C M, et al. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys[J]. Health Technology Assessment, 2011, 15(20): 1-234, iii-iv. [5] Basch E. The missing voice of patients in drug-safety reporting[J]. New England Journal of Medicine, 2010, 362(10): 865. [6] Blenkinsopp A, Wilkie P, Wang M, et al. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience[J]. British Journal of Clinical Pharmacology, 2007, 63(2): 148-156. [7] Anderson C, Krska J, Murphy E, et al. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective[J]. British Journal of Clinical Pharmacology, 2011, 72(5): 806-822. [8] 王丹, 程刚. 药品不良反应监测数据年度趋势分析[J]. 药物流行病学杂志, 2013, 22(5): 238-241. [9] 郑明节, 王春婷. 我国患者报告药品不良反应的现状和对策分析[J]. 中国药物警戒, 2014, 11(10): 618-620. [10] van Hunsel F, H rmark L, Pal S, et al. Experiences with adverse drug reaction reporting by patients: an 11-country survey[J]. Drug safety, 2012, 35(1): 45-60. [11] H rmark L, van Hunsel F, Grundmark B. ADR reporting by the general public: lessons learnt from the Dutch and Swedish systems[J]. Drug safety, 2015, 38(4): 337-347. [12] Robertson J, Newby D A. Low awareness of adverse drug reaction reporting systems: a consumer survey[J]. Medical Journal of Australia, 2013, 199(10): 684-686. [13] Ting K N, Stratton-Powell D M, Anderson C. Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study[J]. International Journal of Clinical Pharmacy, 2010, 32(3): 339-342. [14] 蔡蓝, 高亚, 李嘉伟,等. 广东省公众对药品不良反应的认知现状调查分析[J]. 中国药房, 2015,26(21):2887-2889. [15] 张桂菊,初晓艺,田月洁,等.欧盟药物警戒体系对我国的启示[J].中国药物警戒, 2015, 12(10) : 593-596. |